Regional and cellular gene expression changes in human Huntington's disease brain. - Wikidata - wikimedia - TriplyDB

Regional and cellular gene expression changes in human Huntington's disease brain.

Regional and cellular gene expression changes in human Huntington's disease brain.

http://www.wikidata.org/entity/Q33233457

about

The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's disease Genome-wide siRNA screen reveals amino acid starvation-induced autophagy requires SCOC and WAC Therapeutic potential of mood stabilizers lithium and valproic acid: beyond bipolar disorder The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic mice.Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia Modeling Huntington's disease with induced pluripotent stem cells Possible involvement of self-defense mechanisms in the preferential vulnerability of the striatum in Huntington's disease Genetics and neuropathology of Huntington's disease Transcriptional dysregulation in Huntington's disease: a failure of adaptive transcriptional homeostasis N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice Reinstating aberrant mTORC1 activity in Huntington's disease mice improves disease phenotypes.The Wnt receptor Ryk reduces neuronal and cell survival capacity by repressing FOXO activity during the early phases of mutant huntingtin pathogenicity AAV-dominant negative tumor necrosis factor (DN-TNF) gene transfer to the striatum does not rescue medium spiny neurons in the YAC128 mouse model of Huntington's disease Maintenance of basal levels of autophagy in Huntington's disease mouse models displaying metabolic dysfunction Does neuroinflammation fan the flame in neurodegenerative diseases?RNA-mediated pathogenic mechanisms in polyglutamine diseases and amyotrophic lateral sclerosis Striatal-enriched protein tyrosine phosphatase expression and activity in Huntington's disease: a STEP in the resistance to excitotoxicity Structure, binding interface and hydrophobic transitions of Ca2+-loaded calbindin-D(28K)A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease Human accelerated region 1 noncoding RNA is repressed by REST in Huntington's disease The bifunctional microRNA miR-9/miR-9* regulates REST and CoREST and is downregulated in Huntington's disease CRNDE: A Long Non-Coding RNA Involved in CanceR, Neurobiology, and DEvelopment Unbiased gene expression analysis implicates the huntingtin polyglutamine tract in extra-mitochondrial energy metabolism DEGAS: de novo discovery of dysregulated pathways in human diseases Decreased striatal RGS2 expression is neuroprotective in Huntington's disease (HD) and exemplifies a compensatory aspect of HD-induced gene regulation Functional roles for the striatal-enriched transcription factor, Bcl11b, in the control of striatal gene expression and transcriptional dysregulation in Huntington's disease An evolutionarily conserved long noncoding RNA TUNA controls pluripotency and neural lineage commitment Genome-wide loss of 5-hmC is a novel epigenetic feature of Huntington's disease Nanopublications for exposing experimental data in the life-sciences: a Huntington's Disease case study Huntington’s disease blood and brain show a common gene expression pattern and share an immune signature with Alzheimer’s disease Improvement of neuropathology and transcriptional deficits in CAG 140 knock-in mice supports a beneficial effect of dietary curcumin in Huntington's disease.A novel method for fast Change-Point detection on simulated time series and electrocardiogram data Mice lacking caspase-2 are protected from behavioral changes, but not pathology, in the YAC128 model of Huntington disease.Expression analysis of novel striatal-enriched genes in Huntington disease.Assessment of the relationship between pre-chip and post-chip quality measures for Affymetrix GeneChip expression data.Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral blood.Alterations in cortical excitation and inhibition in genetic mouse models of Huntington's disease.Transgenic mice expressing caspase-6-derived N-terminal fragments of mutant huntingtin develop neurologic abnormalities with predominant cytoplasmic inclusion pathology composed largely of a smaller proteolytic derivative.Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington's disease monkeys.Molecular networks involved in mouse cerebral corticogenesis and spatio-temporal regulation of Sox4 and Sox11 novel antisense transcripts revealed by transcriptome profiling.

P2860

Q24293871-9AA1ADFC-9502-496F-AF0F-2F5CC055FFE4 Q24305544-6EDB672F-34EB-4A02-83CC-DC7DC88BB597 Q24626017-74FDF81F-9D0C-48B7-B5D7-CAE99C83CAA7 Q24656405-544482E7-C90A-43D4-9C0C-1DC6474A6A39 Q24670103-BD6E4EBB-80C6-4FBF-94EA-873EBA9AAE96 Q27004209-B89CE383-1BB2-4EA5-83C6-CBCA461653C8 Q27011417-3C96F673-8890-4E86-A625-F058241EE877 Q27023050-0DAB20FE-439B-4B4C-8D0D-00A01434A2FD Q27026549-CAABB138-D55A-47B2-9718-D8B5ECB5AC9D Q27306025-6B960905-2301-4106-867A-50D0D52CDB6E Q27306293-9467C590-1E11-4A0E-8A63-7FFF7C551851 Q27314681-4FC6AAEB-997E-47AD-BB2E-E9B5251C89D9 Q27334472-61053591-BAEF-4722-843A-FF104CCACB93 Q27341821-2CFA9FB5-8962-4492-A5C4-E48196DA866E Q27498993-1F8C965A-8EE6-46E6-A912-0699020A3B4C Q28082520-5A6AC24B-349D-49C2-A319-88A14C029E3F Q28239309-C1ED5ACC-B2F3-40F0-AFF3-C591DC93389F Q28248378-73EEA16D-DEB5-4A89-8D8B-39D214A02805 Q28252463-C50487ED-68DA-412F-846E-91FCBD03A1D2 Q28274070-9AFF010D-FA32-46AD-AC64-29DF0BD151C6 Q28305485-11508836-9CCF-4989-93E9-F794CBD1058C Q28391523-8041F312-7933-4055-B17D-E3EDAB162A1F Q28469280-0CFE20EF-558F-488D-BC0B-26566251AD43 Q28475850-4D9E2878-57DA-41CC-A3E4-A00EAC894E4A Q28479035-B8D18149-6C90-49F7-991F-40D15D2D5E8C Q28507781-DB9E57E7-09F9-4759-9366-8D4D61B035C2 Q28585984-B9C2DF7D-DF09-4AB3-B60D-1D5B6468D3D3 Q28594357-F4068957-55F5-419A-8A66-CD499A64C50E Q28606409-AC112346-1620-4C5F-9CF4-C9D9D768F116 Q29248581-2BEA4CA0-7AC4-4D0F-AB3D-474B1CB73557 Q30426968-C990610B-8266-41EB-9691-B0C001BEF4DB Q30440547-B7080C40-DAB0-477E-B24B-334AB3E1AAA3 Q30474047-EE1CFEE4-DC5F-478F-A183-075B032E410D Q30476999-BCD8D1BF-3FF5-432D-8267-98355992DFF4 Q30477694-5F3EA387-6517-4676-A895-EF91CAB2AE88 Q30480013-2CEF4B48-6781-4AA1-B2F8-D95EFD885135 Q30490632-9B821A80-C9D1-49E3-9F71-494C1E16B7AA Q30501353-DE00F753-CA7D-4FE4-8149-5CC51A0D0F80 Q30543574-85F8F840-C14F-4F0C-8B1C-BBC4369E0571 Q30874655-5E9756F0-E51D-4F99-BBBF-C715190A1839

P2860

Regional and cellular gene expression changes in human Huntington's disease brain.

http://www.wikidata.org/entity/Q33233457

description

2006 nî lūn-bûn

@nan

2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Regional and cellular gene expression changes in human Huntington's disease brain.

@ast

Regional and cellular gene expression changes in human Huntington's disease brain.

@en

type

label

Regional and cellular gene expression changes in human Huntington's disease brain.

@ast

Regional and cellular gene expression changes in human Huntington's disease brain.

@en

prefLabel

Regional and cellular gene expression changes in human Huntington's disease brain.

@ast

Regional and cellular gene expression changes in human Huntington's disease brain.

@en

P1433

Q33233457-D821AAA3-8804-4220-9520-47A2FC20A9F2

P1476

Q33233457-53206B72-554A-4202-9875-B696D13E82F3

P2093

Q33233457-2299BF4D-EBE5-40DE-9F54-93535283656E

Q33233457-2A830D11-5920-4C65-8B05-AFCE397664FA

Q33233457-32A3DECF-AD68-427A-9C71-BD3686EB3004

Q33233457-3A7A1FB5-E065-47BF-AD33-46AA2DEDBD65

Q33233457-43B23B4E-95F7-4B19-91B8-16032D33D2DB

Q33233457-45042886-1FC6-47E6-B84E-BE5822A3657C

Q33233457-5E4F7AFB-B9DD-42AB-A6D3-59A673D0674D

Q33233457-68581386-345A-4ED4-A128-C51642DF19BF

Q33233457-7B819DD5-925E-45B0-9B62-1AB7B0F87467

Q33233457-8774823B-3E79-4C1C-A5D1-A0036C36A6B7

P304

Q33233457-AB07D8DD-CF99-42E9-880B-E92E8A6DE9C7

P31

Q33233457-3A0FA5CA-1F5C-40B8-AD44-15FCB6FF315E

P356

Q33233457-171CEE2B-5C0E-4E74-B29E-5BB3E616DDAF

P433

Q33233457-9AAC4102-00F7-4FC0-B07F-8AE6884FABF4

P478

Q33233457-9E86C3C0-62A8-4A1A-97FD-0142ABB1D2F2

P50

Q33233457-011CE235-7C39-429B-9439-05712C2A910D

Q33233457-496E0CF0-A215-441F-ACB6-E7AB87F36485

Q33233457-8E0E9880-74FF-4BD6-A5FC-6CA69EE8DE5E

Q33233457-FF74B68D-B6B2-44A5-9BC7-2F37D2643AAB

P577

Q33233457-15D85D1C-6E43-407C-9FF1-281D54D2FE24

P5875

Q33233457-5DEDE355-91F8-4EE7-B271-290083369B94

P698

Q33233457-FF618A88-5EE2-4C72-B247-89CBE31F11C8

P921

Q33233457-E99BD767-D62B-4AB4-B6B8-9F642E8181BB

P356

P1433

Human Molecular Genetics

P1476

Regional and cellular gene expression changes in human Huntington's disease brain.

@en

P2093

Aaron K Aragaki

http://www.w3.org/2001/XMLSchema#string

Alexandre Kuhn

http://www.w3.org/2001/XMLSchema#string

Andrew D Strand

http://www.w3.org/2001/XMLSchema#string

Anne B Young

http://www.w3.org/2001/XMLSchema#string

Beth Synek

http://www.w3.org/2001/XMLSchema#string

Cathy Hartog

http://www.w3.org/2001/XMLSchema#string

Darlene R Goldstein

http://www.w3.org/2001/XMLSchema#string

Doris Thu

http://www.w3.org/2001/XMLSchema#string

Francois Collin

http://www.w3.org/2001/XMLSchema#string

Gareth Hughes

http://www.w3.org/2001/XMLSchema#string

P304

965-977

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HMG/DDL013

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Charles Kooperberg

Ruth Luthi-Carter

P577

2006-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7307756

http://www.w3.org/2001/XMLSchema#string

P698

16467349

http://www.w3.org/2001/XMLSchema#string

P921

Huntington disease